PharmaNutra SpA (CHIX:PHNM) Net Interest Margin (Bank Only) %


CHIX:PHNM PharmaNutra SpA CHIX:PHNM
83 GF Score
Price €87.90
GF Value €56.69
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is PharmaNutra SpA Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

CHIX:PHNM
83GF Score
PharmaNutra SpA CHIX:PHNM
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is PharmaNutra SpA (CHIX:PHNM) Overvalued in 2026?

Based on GuruFocus' analysis, PharmaNutra SpA stock appears to be overvalued. The current stock price of €87.90 is trading 55.1% above its estimated GF Value™ of €56.69. GuruFocus considers PharmaNutra SpA to be Significantly Overvalued.

Key valuation signals for CHIX:PHNM:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: €56.69 vs. price of €87.90 (55.1% above fair value)
  • GF Score™: 83/100 with 6 warning signs

No single metric tells the full story. See the CHIX:PHNM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PharmaNutra SpA Business Description

Other Exchanges PHN:Italy761:Germany
Address Via Campodavela 1, Pisa, ITA, 56122
PharmaNutra SpA is a pharmaceutical company. The company is engaged in the research, design, development, and marketing of nutraceutical supplements and medical devices. The products of the company include SiderAL Folic, UltraMag, Cetilar, and others. The company operates in Europe, the Middle East, South America, the Far East, and other regions.
83GF Score

Get the complete analysis for CHIX:PHNM

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€87.90
Price
€56.69
GF Value